Tag

NASDAQ: RZLT

Amylyx Pharmaceuticals details 55% hypoglycemia reduction in Phase 3
Adrian Kessler · Nov 14, 2026
Rezolute reports 13 responders in preliminary Phase 3 tumor study
Adrian Kessler · Nov 13, 2026
Rezolute says FDA recommends pre‑BLA meeting after congenital HI trial miss
Adrian Kessler · Oct 6, 2026